MENU
IMRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immuneering (IMRX) Earnings Date & Reports
Immuneering Corp is a biopharmaceutical company... Show more
A.I. Advisor
published Earnings
IMRX is expected to report earnings to rise 44.67% to -30 cents per share on November 05
Q3'26
Est.
$-0.30
Q1'26
Beat
by $0.04
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.02
The last earnings report on May 15 showed earnings per share of -20 cents, beating the estimate of -25 cents. With 571.71K shares outstanding, the current market capitalization sits at 275.29M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
53
Web
https://www.immuneering.com